Pancreatic Cancer

TF ADC Competition Accelerates: Zai Ding Files for Cervical Cancer Approval, Xin Nuo Wei Launches Phase III for Pancreatic Cancer

by
TF ADC Competition Accelerates: Zai Ding Files for Cervical Cancer Approval, Xin Nuo Wei Launches Phase III for Pancreatic Cancer

Click the blue text Follow us This Issue Highlights Currently, the only approved TF-ADC drug globally is Seagen’s TIVDAK (tisotumab vedotin-tftv, for cervical cancer), with a carrier of VA–MMAE. It has been approved for sale in Japan. The domestic sales are handled by Zai Ding Pharmaceutical, which has submitted a listing application. Xin Nuo Wei’s … Read more

Decoding the Innovation Power of Chengxi: How AI and Robotics from DAMO Academy are Transforming the Industry!

by
Decoding the Innovation Power of Chengxi: How AI and Robotics from DAMO Academy are Transforming the Industry!

Future Technology City Alibaba Medical AI Model Recognized by International Authorities! Recently, the AI model for pancreatic cancer screening developed by Lake House Laboratory (Alibaba DAMO Academy) – DAMO PANDA, has been recognized by the FDA as a “Breakthrough Medical Device”! The FDA (U.S. Food and Drug Administration) established the “Breakthrough Medical Device” designation in … Read more

Establishment and Application of Preoperative Scoring System for Resectable Pancreatic Cancer

by
Establishment and Application of Preoperative Scoring System for Resectable Pancreatic Cancer

Pancreatic cancer is a highly malignant and lethal tumor, with a high incidence and extremely poor prognosis. According to the 2021 cancer data from the United States, the incidence of pancreatic cancer continues to rise, ranking 10th among new cases in men and 9th in women, with a mortality rate that ranks 4th among all … Read more